Peruvian research output is one of the lowest in South America and is limited to the work of a small group of institutions and related to few subjects, such as infectious diseases. We determined the proportion of subsequent publication and its associated factors of the abstracts with Peruvian affiliation presented to the American Society of Tropical Medicine and Hygiene annual meetings between 2006 and 2010. Approximately 27% (79/296) of abstracts were published within 6 years of presentation, with a median time to publication of 16 months (interquartile range: 9-28). In the adjusted analysis, abstracts with a higher proportion of authors from Peruvian institutions were less likely to be published (risk ratio: 0.5; 95% CI: 0.3-0.8). In conclusion, one of four of the analyzed abstracts was published. Even though this proportion is higher than that in other meetings in Peru and South America, publication rates-especially among Peruvian-only collaborations-still need to be improved.
Aim: In December 2019, there were reports of a new type of coronavirus that affects the different health systems of the world. We have carried out a systematic review of the possible antivirals studied that could be useful in this public health catastrophe.
Data Sources: A search strategy with MESH terms was performed in PubMed, Web of Science, and Scopus. Also, RCTs published in clinicaltrials.gov were reviewed. The databases were searched between April and June 2020.
Study Selection: We selected all Randomized Controlled Trials evaluating the effects of antivirals and 5 studies were included from a research database of 280 articles collected between. After removing duplicated articles, 43 were selected for review. Finally, 5 articles were eligible for full-text review and included in the article.
Results: Current randomized controlled trial data showed no clinical improvement in terms of mortality, need for oxygen support or need for intubation in patients who used antivirals versus those who did not. No clinical improvement was demonstrated. It was observed that there is difficulty in calculating clinical improvement, this large difference makes the eligible studies difficult to compare.
Conclusion: These predictors, however, need further work to validate reliability. More clinical trials involving antivirals are needed to observe a relationship between clinical improvement or mortality from SARS-CoV-19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.